China Pharma Holdings, Inc. (CPHI) DCF Valuation

China Pharma Holdings, Inc. (CPHI) DCF Valuation
  • ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
  • ✓ Design Profissional: Modelos Confiáveis ​​E Padrão Da Indústria
  • ✓ Pré-Construídos Para Uso Rápido E Eficiente
  • ✓ Não É Necessária Experiência; Fácil De Seguir

China Pharma Holdings, Inc. (CPHI) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

As an investor or analyst, the (CPHI) DCF Calculator is your go-to resource for accurate valuation. Featuring real data from China Pharma Holdings, Inc., you can easily adjust forecasts and observe the effects in real time.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 10.9 10.9 9.6 8.1 7.0 6.3 5.6 5.1 4.5 4.1
Revenue Growth, % 0 -0.52625 -11.27 -15.95 -13.48 -10.31 -10.31 -10.31 -10.31 -10.31
EBITDA -17.5 .1 .2 -.8 .0 -1.3 -1.2 -1.1 -1.0 -.9
EBITDA, % -159.75 0.98332 2.39 -10.34 0.12032 -21.37 -21.37 -21.37 -21.37 -21.37
Depreciation 2.9 2.7 3.1 2.7 2.8 2.0 1.8 1.6 1.4 1.3
Depreciation, % 26.81 24.66 32.02 33.32 39.27 31.22 31.22 31.22 31.22 31.22
EBIT -20.4 -2.6 -2.9 -3.5 -2.7 -3.0 -2.7 -2.4 -2.1 -1.9
EBIT, % -186.57 -23.67 -29.64 -43.66 -39.15 -47.22 -47.22 -47.22 -47.22 -47.22
Total Cash 1.1 1.0 4.9 2.0 1.4 1.4 1.3 1.2 1.0 .9
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .7 .6 .8 .5 .7
Account Receivables, % 6.24 5.37 8.66 5.73 9.45
Inventories 3.6 3.7 3.3 2.9 3.7 2.4 2.2 1.9 1.7 1.6
Inventories, % 32.85 34.1 34.64 36.37 53.24 38.24 38.24 38.24 38.24 38.24
Accounts Payable 1.4 1.2 .9 .7 1.0 .7 .6 .6 .5 .5
Accounts Payable, % 12.51 11.36 9.61 8.23 13.78 11.1 11.1 11.1 11.1 11.1
Capital Expenditure -.1 -.9 -.4 -.4 .0 -.2 -.2 -.2 -.2 -.2
Capital Expenditure, % -1.24 -7.98 -4.54 -4.96 -0.16426 -3.78 -3.78 -3.78 -3.78 -3.78
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -20.7 -2.8 -3.3 -9.1 -2.7 -3.0 -2.7 -2.4 -2.1 -1.9
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -20.8 -1.2 -.9 -6.3 -.7 .0 -.9 -.8 -.7 -.6
WACC, % 7.28 7.28 7.28 7.28 7.28 7.28 7.28 7.28 7.28 7.28
PV UFCF
SUM PV UFCF -2.4
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -1
Terminal Value -12
Present Terminal Value -9
Enterprise Value -11
Net Debt 3
Equity Value -14
Diluted Shares Outstanding, MM 3
Equity Value Per Share -4.25

What You Will Get

  • Real CPHI Data: Preloaded financials – encompassing revenue to EBIT – based on actual and projected figures.
  • Full Customization: Modify all essential parameters (yellow cells) such as WACC, growth %, and tax rates.
  • Instant Valuation Updates: Automatic recalculations to evaluate the effects of changes on CPHI’s fair value.
  • Versatile Excel Template: Designed for quick edits, scenario analysis, and comprehensive projections.
  • Time-Saving and Accurate: Bypass the hassle of building models from scratch while ensuring precision and adaptability.

Key Features

  • 🔍 Real-Life CPHI Financials: Pre-filled historical and projected data for China Pharma Holdings, Inc. (CPHI).
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate CPHI’s intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize CPHI’s valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  1. Download the Template: Gain immediate access to the Excel-based CPHI DCF Calculator.
  2. Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and additional factors.
  3. Instant Calculations: The model automatically recalculates the intrinsic value of China Pharma Holdings, Inc. (CPHI).
  4. Test Scenarios: Experiment with various assumptions to assess potential changes in valuation.
  5. Analyze and Decide: Leverage the results to inform your investment or financial analysis decisions.

Why Choose This Calculator for China Pharma Holdings, Inc. (CPHI)?

  • Accurate Data: Up-to-date financial information for CPHI ensures trustworthy valuation outcomes.
  • Customizable: Modify essential parameters such as growth rates, WACC, and tax rates to align with your forecasts.
  • Time-Saving: Pre-configured calculations save you the hassle of starting from the ground up.
  • Professional-Grade Tool: Tailored for investors, analysts, and consultants focused on CPHI.
  • User-Friendly: Simple interface and guided instructions make it accessible for all users.

Who Should Use This Product?

  • Investors: Evaluate China Pharma Holdings, Inc.'s (CPHI) market position before making investment decisions.
  • CFOs and Financial Analysts: Optimize valuation methodologies and analyze financial forecasts for CPHI.
  • Startup Founders: Understand the valuation strategies of established companies like China Pharma Holdings, Inc. (CPHI).
  • Consultants: Create detailed valuation assessments and reports for clients focusing on CPHI.
  • Students and Educators: Utilize real-time data from China Pharma Holdings, Inc. (CPHI) to enhance learning on valuation practices.

What the Template Contains

  • Pre-Filled DCF Model: China Pharma Holdings, Inc.’s (CPHI) financial data preloaded for immediate use.
  • WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
  • Financial Ratios: Evaluate China Pharma Holdings, Inc.’s (CPHI) profitability, leverage, and efficiency.
  • Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
  • Financial Statements: Annual and quarterly reports to support detailed analysis.
  • Interactive Dashboard: Easily visualize key valuation metrics and results.

No products were found matching.